Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7201.00 | 7143.75 | 1.0080 | 1.0062 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7393.00 | 7143.75 | 1.0349 | 1.0267 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 5000.00 | 1193.65 | 7242.00 | 7143.75 | 1.0138 | 1.0106 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7038.00 | 7143.75 | 0.9852 | 0.9885 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6428.00 | 7143.75 | 0.8998 | 0.9199 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6457.00 | 7143.75 | 0.9039 | 0.9232 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6784.00 | 7143.75 | 0.9496 | 0.9604 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1193.65 | 6969.00 | 7143.75 | 0.9755 | 0.9809 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 5386.00 | 7143.75 | 0.7540 | 0.7927 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 2115.00 | 7143.75 | 0.2961 | 0.2481 |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 5000.00 | 1193.65 | 5189.00 | 7143.75 | 0.7264 | 0.7670 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 5000.00 | 1193.65 | 7671.00 | 7143.75 | 1.0738 | 1.0559 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7510.00 | 7143.75 | 1.0513 | 1.0391 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 5000.00 | 1193.65 | 7278.00 | 7143.75 | 1.0188 | 1.0145 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 3828.00 | 7143.75 | 0.5359 | 0.5706 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 7782.00 | 7143.75 | 1.0893 | 1.0674 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 7117.00 | 7143.75 | 0.9963 | 0.9971 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 7458.00 | 7143.75 | 1.0440 | 1.0336 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 5000.00 | 1193.65 | 7548.00 | 7143.75 | 1.0566 | 1.0431 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 5000.00 | 1193.65 | 7276.00 | 7143.75 | 1.0185 | 1.0143 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7245.00 | 7143.75 | 1.0142 | 1.0109 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7481.00 | 7143.75 | 1.0472 | 1.0361 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 5000.00 | 1193.65 | 2447.00 | 7143.75 | 0.3425 | 0.3206 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7805.00 | 7143.75 | 1.0926 | 1.0698 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 6959.00 | 7143.75 | 0.9741 | 0.9798 |